Lexicon Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lexicon Pharmaceuticals, Inc.
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.
The companies will launch "precision medicine strategies" for chronic disease that use Renalytix' AI-enabled IVDs.
The Mount Sinai spin-off believes its KindeyIntelX system can identify COVID-19 patients at high risk for long-term kidney damage.
Editas regains rights to ocular programs first partnered with Allergan in 2017. Newly public F-star will focus on bispecific antibodies for cancer, TriSalus acquires oncology candidate from Dynavax.
Drug Discovery Tools
- Drug Discovery Tools